Combining health data with whole genome sequence data in can

Researchers evaluated the impact of integrating whole-genome sequencing data with clinical outcomes across 13,880 tumors from 33 cancer types, assessing precision care potentials within the UK NHS through the 100,000 Genomes Cancer Programme.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Sequencin Hiseq , Cancer Programme , National Genomic Test Directory , Cambridge South Research Ethics Committee , Research Environment , National Cancer Registration , Analysis Service , Genomic Medicine Service , Genomes Cancer Programme , Public Health England , Office For National Statistics , National Genomic Research Library , International Organization For Standardization , United Kingdom National Healthcare System , Nature Medicine , National Healthcare System , Image Credit , United Kingdom Government , International Organization , Medicine Service , National Genomic Test , Sample Handling Guidance , Illumina Truseq Polymerase Chain Reaction , High Throughput Sequencin , Illumina North Star , Illumina Dragen , Catalogue Of Somatic Mutations In Cancer , Clinical Variant Database , Genomic Tumor Advisory Boards , Homologous Recombination Deficiency Detection , England Cambridge South Research Ethics , Cancer Genome Atlas , Hospital Episode Statistics , Molecular Tumor Boards , Breast Cancer Type , Cyclin Dependentkinase Inhibitor , Cancer , Enome , Bioinformatics , Arcinoma , Carcinomas , Na , Gene , Genes , Enomic , Genomics , Germline , Healthcare , Illumina , Medicine , Ncology , Pharmacogenomics , Protein , Research , Software , Humor ,